Survival in cancer of unknown primary site: population-based analysis by site and histology
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314 · cited 1×
“Regulatory T cells are strongly suppressive of immune reactions and are known to be present in high numbers in ovarian cancer [25].”
BackgroundSelf-citationSystematic Review of the Literature: Parental Outcomes After Diagnosis of Fetal Anomaly
Wool, C. (2011) · Advances in Neonatal Care · doi:10.1097/anc.0b013e31821bd92d · Cited by 952
Diagnostic and therapeutic management of cancer of an unknown primary
Pavlidis, N., Briasoulis, E., Hainsworth, J., & Greco, F. A. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00547-1 · Cited by 597 · cited 2×
“In contrast, liver metastasis and the involvement of multiple sites including the brain, the lung/pleura and bone signal an unfavorable prognosis [1, 3, 12, 13, 18, 19].”
BackgroundFizazi, K., Greco, F. A., Pavlidis, N., Daugaard, G., Oien, K., & Pentheroudakis, G. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv305 · Cited by 453
Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.
Abbruzzese, J. L., Abbruzzese, M. C., Lenzi, R., Hess, K. R., & Raber, M. N. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.8.2094 · Cited by 320 · cited 2×
“Prognosis was shown to be better when a likely primary tumor was identified and the appropriate treatment was applied accordingly [11].”
BackgroundMALIGNANT MELANOMA OF UNKNOWN PRIMARY ORIGIN.
DASGUPTA, T., Bowden, L., & Berg, J. W. (1963) · PubMed · Cited by 249
Carcinoma of unknown primary (CUP)
Pavlidis, N., & Fizazi, K. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.09.005 · Cited by 243
Hess, K. R., Abbruzzese, M. C., Lenzi, R., Raber, M. N., & Abbruzzese, J. L. (1999) · PubMed · Cited by 230
Kamposioras, K., Pentheroudakis, G., Pectasides, D., & Pavlidis, N. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.04.007 · Cited by 161 · cited 1×
“A recent review of the global literature on CUP melanoma identified skin involvement in 222 patients, visceral tissue involvement in 211 patients and bone involvement in 31 patients; median survival in the visceral involvement group was given as 3–16 months [28].”
BackgroundDo all roads lead to Rome? Routes to metastasis development
Sleeman, J. P., Nazarenko, I., & Thiele, W. (2011) · International Journal of Cancer · doi:10.1002/ijc.26027 · Cited by 150 · cited 1×
“Nonetheless, survival does vary according to which lymph nodes are affected [1, 12, 13, 20].”
BackgroundCancer metastasis networks and the prediction of progression patterns
Chen, L. L., Blumm, N., Christakis, N. A., Barabási, A.-L., & Deisboeck, T. S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605214 · Cited by 111 · cited 1×
“ICD-9 codes were used in the present study because these codes define the location of metastasis according to primary affected organ sites [24].”
MethodTreatment for Patients With Unknown Primary Carcinoma and Unfavorable Prognostic Factors
Greco, F. A., & Pavlidis, N. A. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.10.005 · Cited by 104 · cited 9×
“Fizazi K, Greco FA, Pavlidis N, Pentheroudakis G. Cancer of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.”
BackgroundInfluentialDiagnosis of Metastatic Neoplasms: Molecular Approaches for Identification of Tissue of Origin
Monzon, F. A., & Koen, T. J. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.2.216 · Cited by 89
Familial Risks in Cancer of Unknown Primary: Tracking the Primary Sites
Hemminki, K., Ji, J., Sundquist, J., & Shu, X. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5614 · Cited by 61 · cited 2×
“It has been used in recent studies on CUP [6, 22].”
BackgroundMethodSelf-citation
Cited by
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Krämer, A., Bochtler, T., Pauli, C., Baciarello, G., Delorme, S., Hemminki, K., Mileshkin, L., Moch, H., Oien, K., Olivier, T., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2022.11.013 · Cited by 221
Self-citation
Metadata
- Authors
- Hemminki, K., Bevier, M., Hemminki, A., & Sundquist, J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 23
- Issue
- 7
- Pages
- 1854-1863
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2112642339
- Cited by
- 161
- References
- 14
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.